Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$14.45 - $20.34 $145,106 - $204,254
-10,042 Reduced 44.88%
12,333 $181,000
Q2 2023

Aug 04, 2023

SELL
$17.13 - $23.74 $5.75 Million - $7.98 Million
-335,949 Reduced 93.76%
22,375 $419,000
Q1 2023

May 11, 2023

BUY
$19.34 - $24.11 $6.7 Million - $8.35 Million
346,399 Added 2904.81%
358,324 $8.07 Million
Q4 2022

Feb 07, 2023

SELL
$12.64 - $25.52 $107,604 - $217,251
-8,513 Reduced 41.65%
11,925 $302,000
Q3 2022

Nov 10, 2022

BUY
$12.14 - $18.42 $248,117 - $376,467
20,438 New
20,438 $248,000
Q2 2021

Aug 04, 2021

SELL
$26.65 - $39.47 $169,707 - $251,344
-6,368 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$31.9 - $36.0 $203,139 - $229,248
6,368 New
6,368 $229,000

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.